Combining a daily regimen of THC and CBD offers significant relief for late-stage dementia patients while easing the severe burden placed on their caregivers, according to new clinical research. Led in part by experts at the University of Kentucky’s Sanders-Brown Center on Aging, the trial evaluated hospice-eligible individuals who received oral cannabis oil treatments directly in their homes.
The findings revealed an eight-point drop in patient agitation—a decrease lead researcher Dr. Greg Jicha described as “striking”—leaving participants noticeably calmer, more alert, and comfortable. Beyond easing individual distress like pacing and moaning, the treatment led to measurable improvements in overall quality of life for family members managing round-the-clock home care. While most modern Alzheimer’s research focuses on early prevention, this study highlights a vital symptom-management path for advanced stages where effective treatments remain scarce. Despite these encouraging results, Dr. Jicha noted that dementia is still omitted from Kentucky’s qualifying conditions under its current medical cannabis laws.
Dabbin-Dad Newsroom
